Angiogenesis and Vascular Disease joint with Mitochondria, Metabolism and Heart Organizer(s): Luisa Iruela-Arispe, Timothy T. Hla and Courtney Griffin Date: May 08 - 12, 2017 Location: Eldorado Hotel & Spa, Santa Fe, NM, USAAngiogenesis is critical to both the growth and repair of tissues as well as for the progression of several pathologies. Progress in our molecular understanding of vascular growth has facilitated the development of therapies that have been successfully applied in diseases such as retinopathy and cancer. Notwithstanding these advancements, much remains to be harnessed from the basic molecular mechanisms that control vascular growth. This conference will bring together leaders of research from basic science, translational science, biotechnology and pharmaceutical areas, to discuss progress in clinical and translational research areas. The goal of the conference is to highlight new discoveries, technological advances and therapeutic possibilities. Both established and up-and-coming investigators will have ample opportunities to interact informally and share views with junior investigators and trainees in a collegial and relaxed atmosphere. By promoting cross-disciplinary interactions, the meeting will enhance vascular biology research and applications to clinical medicine. Scholarship Deadline: January 11 2017 Discounted Abstract Deadline: January 11 2017 Abstract Deadline: February 8 2017 Discounted Registration Deadline: March 8 2017 We gratefully acknowledge additional support for this conference from:
Bio-Techne
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
EMBO Young Investigator Programme
Pfizer Research Technology Center
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:   We gratefully acknowledge the generous grant for this conference provided by: National Heart, Lung, and Blood Institute (NHLBI)Grant No. 1R13HL137302-01 Funding for this conference was made possible (in part) by HL137302-01 from the National Heart, Lung and Blood Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |